Background illustration for clinical trials search

Paid Clinical Trials New Jersey

Discover 1,658 paid clinical trials in New Jersey. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

for
Myelofibrosis
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06773195

Phase1, Phase2, Recruiting

Evaluating Novel Therapies in ctDNA Positive GI Cancers

for
Colon Adenocarcinoma, Rectal Adenocarcinoma,
Location: Hackensack NJ, Washington DC
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT05482516

Phase3, Recruiting

Comparison of Two Physical Activity Interventions in Individuals With Multiple Sclerosis

for
Multiple Sclerosis
Location: East Hanover NJ
Sponsor: Kessler Foundation

Sex: All

Age: 18 - 65

Code: NCT02496416

Recruiting

Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer

for
Urothelial Carcinoma
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05239624

Phase2, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Providence RI, New Haven CT, Lebanon NH, Quebec,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

for
Mesothelin Positive, Mesothelin-Expressing Tumors,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06623396

Phase1, Recruiting

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

for
Non-small Cell Lung Cancer
Location: Stony Brook NY, White Plains NY, Paramus NJ,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06712316

Phase2, Phase3, Recruiting

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

for
B-ALL, DLBCL, B ALL, Dlbcl-Ci, DLBCL Unclassifiable,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04512716

Early_phase1, Recruiting

ALTO-100 in Bipolar Disorder With Depression (BD-D)

for
Bipolar Disorder I or II With a Major Depressive Episode
Location: Toms River NJ, Bel Air MD, Gaithersburg MD,
Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70

Code: NCT06656416

Phase2, Recruiting

The Use of Electromagnetic Field (EMF) Treatment in Chronic Spinal Cord Injury (SCI) Patients

for
Incomplete Spinal Cord Injury
Location: West Orange NJ, Miami FL
Sponsor: BrainQ Technologies Ltd.

Sex: All

Age: 18 - 70+

Code: NCT04050696

Recruiting

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

for
Metastatic Non-small Cell Lung Cancer
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04410796

Phase2, Recruiting

Left vs Left Randomized Clinical Trial

for
Heart Failure, Heart Failure With Reduced Ejection Fraction,
Location: Halifax, Boston MA, Hartford CT, New Haven CT, Quebec,
Sponsor: Baylor College of Medicine

Sex: All

Age: 18+

Code: NCT05650658

Recruiting

Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

for
Acute Myocardial Infarction, Coronary Artery Disease
Location: St. John's, Nova Scotia, Quebec, The Bronx NY,
Sponsor: Population Health Research Institute

Sex: All

Age: 18+

Code: NCT05701358

Recruiting

A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia

for
Cachexia
Location: Shirley NY, Hartford CT, East Brunswick NJ,
Sponsor: AVEO Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05865535

Phase1, Recruiting

Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study

for
Chronic Subdural Hematoma
Location: Boston MA, Valhalla NY, The Bronx NY, New York NY,
Sponsor: The University of Texas Medical Branch, Galveston

Sex: All

Age: 40 - 70+

Code: NCT06347796

Recruiting

Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries

for
Pressure Ulcers Stage II, Pressure Ulcers Stage III,
Location: Lake Success NY, Mineola NY, Valhalla NY, The Bronx NY,
Sponsor: ULURU Inc.

Sex: All

Age: 18 - 70+

Code: NCT05496296

Recruiting

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

for
Refractory Acute Myeloid Leukemia,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 1+

Code: NCT06017258

Phase1, Recruiting

Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

for
Prostate Adenocarcinoma
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health

Sex: Male

Age: 18+

Code: NCT06798558

Phase2, Recruiting

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

for
Cancer
Location: New York NY, New Brunswick NJ, Philadelphia PA,
Sponsor: MBrace Therapeutics

Sex: All

Age: 18+

Code: NCT06014658

Phase1, Phase2, Recruiting

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Boston MA, New Haven CT, New York NY, Paramus NJ,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06742996

Phase3, Recruiting

Popular cities in New Jersey

New Jersey is a vital center for a diverse array of clinical trials, largely in part due to its robust healthcare network and prominent medical research institutions. Key organizations such as Rutgers Cancer Institute, Hackensack Meridian Health, and Cooper University Health Care are leading the way in groundbreaking studies in the state. These institutions are recognized for their innovative research in areas like cancer, cardiovascular health, and neurology, making New Jersey a critical player in advancing medical science and patient care.

Why choose New Jersey for clinical trials?

New Jersey offers a vast array of advantages for individuals considering participation in clinical trials. The state has a diverse population, which enriches the participant pool and improves the reliability and applicability of research findings. Additionally, New Jersey is home to some of the nation’s leading medical research institutions, known for their innovative approaches and focus on advancing healthcare.

By choosing to participate in a clinical trial in New Jersey, participants not only gain access to cutting-edge treatments but also play a vital role in advancing important medical research. The state’s well-established clinical research infrastructure ensures participants receive exceptional care and support throughout their journey, contributing to meaningful advancements in healthcare.

Common conditions studied in New Jersey

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in New Jersey